Prostate Cancer
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance.
November 27, 2023
Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
November 27, 2023
Implementation of Physical Therapist Services for men Undergoing Radical Prostatectomy: An Administrative Case Report.
November 27, 2023
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
November 27, 2023
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
November 27, 2023
Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer.
November 24, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
November 24, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
November 23, 2023
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide.
November 23, 2023
Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients' Real-World Insights for Optimizing Outcomes.
November 23, 2023
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
November 23, 2023
A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer.
November 22, 2023
Randomized trial of concomitant hypofractionated IMRT boost versus conventional fractionated IMRT boost for localized high-risk prostate cancer (pHART2-RCT).
November 22, 2023
Practical Use of Self-Adjusted Nitrous Oxide (SANO) During Transrectal Prostate Biopsy: A Double-Blind Randomized-Control Trial.
November 22, 2023